Your totally right about the long term, that's why I invested in them! I just wish I could just stop looking at what the pps does for the next two years! Lol.
Lesgetrich, you might know this because you've been invested with Inmed for a while. I read an article from AMP written in March 2015. The article was talking about the Glacoma drug, at the time it was labeled I think ICM-085. It was saying how Inmed planned on having it in clinacle trials in Q4 2015 or Q1 2016, I couldn't find anything else on it. Did Inmed pull it for further studies or whatever happened with those plans?